Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | CLIC1 | O00299 | 1/20 | 0.46 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8285 | 0.98 | AKR1B1 (0.61) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| SCHEMBL2528595 | 0.98 | AKR1B1 (0.61) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| SCHEMBL29631318 | 0.98 | AKR1B1 (0.61) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| Hydrochloric Acid SCHEMBL2527505 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| Ammonia Solution, Strong SCHEMBL22042026 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| SCHEMBL28532359 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| Water SCHEMBL30372687 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| SCHEMBL30961703 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| SCHEMBL27701670 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD | |
| Ammonia Solution, Strong SCHEMBL27920751 | 0.96 | CTBP2 (0.59) | CTBP2AKR1B1PTGS2TDP1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110194834-B | Visual photoinduced shape memory polymer and preparation method thereof | 西南交通大学 | 2020-07-10 | — | — | CN | disclosed |
| US-9260449-B2 | Method for preparing D-biotin | ZHEJIANG MEDICINE CO., LTD., XINCHANG PHARMACEUTICAL FACTORY (CN) | 2016-02-16 | — | — | US | disclosed |
| CN-103360315-B | Heterocyclic aryloxyacetyl hydrazone derivative and its preparation method and application thereof | UNIV SHANDONG | 2015-03-04 | — | — | CN | disclosed |
| US-20150011777-A1 | METHOD FOR PREPARING D-BIOTIN | ZHEJIANG MEDICINE CO., LTD., XINCHANG PHARMACEUTICAL FACTORY (CN) | 2015-01-08 | — | — | US | disclosed |
| EP-0275139-B1 | ASSAY METHOD USING PARTICLES WITH ASSOCIATED FLUORESCER | SYNTEX (U.S.A.) INC. (US) | 1992-04-15 | — | — | EP | disclosed |
| US-4891324-A | FLUORIMETRY | SYNTEX (U.S.A.) INC. (US) | 1990-01-02 | — | — | US | disclosed |
| EP-0275139-A2 | Assay method using particles with associated fluorescer | SYNTEX (U.S.A.) INC. (US) | 1988-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011777-A1 | METHOD FOR PREPARING D-BIOTIN | BCKDK, DECR1, BTD | CTBP2 1226/4885AKR1B1 251/4885PTGS2 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.